NAGIOS: RODERIC FUNCIONANDO

Efficacy of methylprednisolone on pain, trismus and quality of life following surgical removal of mandibular third molars:a double-blind, split-mouth, randomised controlled trial

Repositori DSpace/Manakin

IMPORTANT: Aquest repositori està en una versió antiga des del 3/12/2023. La nova instal.lació está en https://roderic.uv.es/

Efficacy of methylprednisolone on pain, trismus and quality of life following surgical removal of mandibular third molars:a double-blind, split-mouth, randomised controlled trial

dc.contributor.author	Larsen, Marie Kjærgaard	es
dc.contributor.author	Kofod, Thomas	es
dc.contributor.author	Duch, Kirsten	es
dc.contributor.author	Starch-Jensen, Thomas	es
dc.date.accessioned	2023-06-16T08:36:38Z
dc.date.available	2023-06-16T08:36:38Z
dc.date.issued	2021	es
dc.identifier.citation	Larsen, MK., Kofod, T., Duch, K., & Starch-Jensen, T. (2021). Efficacy of methylprednisolone on pain, trismus and quality of life following surgical removal of mandibular third molars: a double-blind, split-mouth, randomised controlled trial. En Medicina Oral Patología Oral y Cirugia Bucal (pp. e156-e163). Medicina Oral, S.L. https://doi.org/10.4317/medoral.24094	es
dc.identifier.uri	https://hdl.handle.net/10550/88008
dc.description.abstract	The objective of the present study was to compare the efficacy of different doses of methylprednisolone on postoperative sequelae and quality of life (QoL) following surgical removal of mandibular third molars (SRM3). Fifty-two patients (16 men and 36 women, mean age 25.9 years, range: 18-39) with bilateral impacted mandibular third molars were randomly allocated into intraoperative muscular injection of either 20mg, 30mg, 40mg methylprednisolone or saline injection. Baseline measurements were obtained preoperatively and compared with assessment after one day, three days, seven days and one month. Pain and trismus were estimated by visual analog scale score and interincisal mouth opening, respectively. Subjective assessment of QoL included Oral Health Impact Profile (OHIP-14). Descriptive and generalized estimating equation analyses were made and expressed as mean values with a 95% confidence interval. Methylprednisolone revealed no significant differences in pain, trismus and QoL compared with placebo. Higher prevalence of postoperative pain and worsening in QoL were observed with increased age (P=0.00). Smoking and increased time of surgery decreased mouth opening in the early healing phase (P=0.00). The present study revealed no significant improvement of methylprednisolone on postoperative sequelae and QoL following SRM3 compared with placebo.	es
dc.subject	oral health	es
dc.subject	case control study	es
dc.subject	sleep	es
dc.subject	review	es
dc.subject	gingivitis	es
dc.subject	periodontitis	es
dc.subject	tooth loss	es
dc.title	Efficacy of methylprednisolone on pain, trismus and quality of life following surgical removal of mandibular third molars:a double-blind, split-mouth, randomised controlled trial	es
dc.type	journal article	es_ES
dc.subject.unesco	UNESCO:CIENCIAS MÉDICAS	es
dc.identifier.doi	10.4317/medoral.24094	es
dc.type.hasVersion	VoR	es_ES
dc.identifier.url	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980302/